Global Dermatology Market Analysis 2016 - Forecast to 2022

  • ID: 3845814
  • Report
  • Region: Global
  • 114 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Dermatology". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Dermatology Market by Product Type
5.1 Introduction
5.2 Clobex (clobetasol propionate)
5.3 Differin (adapalene)
5.4 Elidel (pimecrolimus)
5.5 Elocon (mometasone furoate)
5.6 Enbrel (etanercept)
5.7 Humira (adalimumab)
5.8 Metolate (methotrexate)
5.9 Neoral (cyclosporine)
5.10 Protopic (tacrolimus)
5.11 Remicade (infliximab)
5.12 Stelara (ustekinumab)
5.13 Zyvox (Linezolid)
5.14 Solodyn (Minocycline Hydrochloride)
5.15 Aczone (Dapsone)

6 Dermatology Market by Application
6.1 Introduction
6.2 Acne (Acne Vulgaris)
6.3 Alopecia
6.4 Dermatitis
6.4.1 Atopic Dermatitis
6.4.2 Contact Dermatitis
6.4.3 Nummular Dermatitis
6.4.4 Perioral Dermatitis
6.4.5 Seborrhoeic Dermatitis
6.5 Psoriasis
6.6 Rosacea
6.7 Skin Cancer
6.8 Skin Infections
6.8.1 Bacterial Skin Infections
6.8.2 Fungal Skin Infections
6.8.3 Viral Skin Infections

7 Dermatology Market by Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 RoW
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Vendor Landscaping
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiles
9.1 Allergan Inc
9.1.1 Business Overview
9.1.2 SWOT Analysis
9.1.3 Financial Overview
9.1.4 Strategy
9.1.5 Key Activities
9.2 AbbVie
9.3 Almirall, S.A
9.4 Bayer AG
9.5 Biofrontera AG
9.6 Derma Sciences
9.7 Galderma (Nestle Skin Health S.A.)
9.8 GlaxoSmithKline (GSK)
9.9 Hill Dermaceuticals Inc.
9.10 Johnson & Johnson
9.11 LEO Pharma
9.12 Merck & Co. Inc
9.13 Merz Pharma
9.14 Novartis Inc.
9.15 Pfizer
9.16 Pierre Fabre
9.17 Stiefel Laboratories, Inc.
9.18 Valeant Pharmaceuticals International Inc.
9.19 Kythera Biopharmaceuticals Inc.
9.20 Zeltiq Aesthetics Inc.

10 Appendix
11 Disclaimer

List of Tables
Table 1 Global Dermatology Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Dermatology Market Analysis, by Product Type, 2013-2022 ($MN)
Table 3 Global Clobex (clobetasol propionate) Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Clobex (clobetasol propionate) Market Analysis, by Application, 2013-2022 ($MN)
Table 5 Global Differin (adapalene) Market Analysis, by Region, 2013-2022 ($MN)
Table 6 Global Differin (adapalene) Market Analysis, by Application, 2013-2022 ($MN)
Table 7 Global Elidel (pimecrolimus) Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Elidel (pimecrolimus) Market Analysis, by Application, 2013-2022 ($MN)
Table 9 Global Elocon (mometasone furoate) Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Elocon (mometasone furoate) Market Analysis, by Application, 2013-2022 ($MN)
Table 11 Global Enbrel (etanercept) Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global Enbrel (etanercept) Market Analysis, by Application, 2013-2022 ($MN)
Table 13 Global Humira (adalimumab) Market Analysis, by Region, 2013-2022 ($MN)
Table 14 Global Humira (adalimumab) Market Analysis, by Application, 2013-2022 ($MN)
Table 15 Global Metolate (methotrexate) Market Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Metolate (methotrexate) Market Analysis, by Application, 2013-2022 ($MN)
Table 17 Global Neoral (cyclosporine) Market Analysis, by Region, 2013-2022 ($MN)
Table 18 Global Neoral (cyclosporine) Market Analysis, by Application, 2013-2022 ($MN)
Table 19 Global Protopic (tacrolimus) Market Analysis, by Region, 2013-2022 ($MN)
Table 20 Global Protopic (tacrolimus) Market Analysis, by Application, 2013-2022 ($MN)
Table 21 Global Remicade (infliximab) Market Analysis, by Region, 2013-2022 ($MN)
Table 22 Global Remicade (infliximab) Market Analysis, by Application, 2013-2022 ($MN)
Table 23 Global Stelara (ustekinumab) Market Analysis, by Region, 2013-2022 ($MN)
Table 24 Global Stelara (ustekinumab) Market Analysis, by Application, 2013-2022 ($MN)
Table 25 Global Zyvox (Linezolid) Market Analysis, by Region, 2013-2022 ($MN)
Table 26 Global Zyvox (Linezolid) Market Analysis, by Application, 2013-2022 ($MN)
Table 27 Global Solodyn (Minocycline Hydrochloride) Market Analysis, by Region, 2013-2022 ($MN)
Table 28 Global Solodyn (Minocycline Hydrochloride) Market Analysis, by Application, 2013-2022 ($MN)
Table 29 Global Aczone (Dapsone) Market Analysis, by Region, 2013-2022 ($MN)
Table 30 Global Aczone (Dapsone) Market Analysis, by Application, 2013-2022 ($MN)
Table 31 Global Dermatology Market Analysis, by Region, 2013-2022 ($MN)
Table 32 Global Dermatology Market Analysis, by Application, 2013-2022 ($MN)
Table 33 Global Acne (Acne Vulgaris) Market Analysis, by Region, 2013-2022 ($MN)
Table 34 Global Acne (Acne Vulgaris) Market Analysis, by Product Type, 2013-2022 ($MN)
Table 35 Global Alopecia Market Analysis, by Region, 2013-2022 ($MN)
Table 36 Global Alopecia Market Analysis, by Product Type, 2013-2022 ($MN)
Table 37 Global Dermatitis Market Analysis, by Region, 2013-2022 ($MN)
Table 38 Global Dermatitis Market Analysis, by Product Type, 2013-2022 ($MN)
Table 39 Global Psoriasis Market Analysis, by Region, 2013-2022 ($MN)
Table 40 Global Psoriasis Market Analysis, by Product Type, 2013-2022 ($MN)
Table 41 Global Rosacea Market Analysis, by Region, 2013-2022 ($MN)
Table 42 Global Rosacea Market Analysis, by Product Type, 2013-2022 ($MN)
Table 43 Global Skin Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 44 Global Skin Cancer Market Analysis, by Product Type, 2013-2022 ($MN)
Table 45 Global Skin Infections Market Analysis, by Region, 2013-2022 ($MN)
Table 46 Global Skin Infections Market Analysis, by Product Type, 2013-2022 ($MN)

Note: Regional tables are presented in the similar manner as the above
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll